Back to Search
Start Over
Safety of recombinant VSV-Ebola virus vaccine vector in pigs.
- Source :
-
Emerging infectious diseases [Emerg Infect Dis] 2015 Apr; Vol. 21 (4), pp. 702-4. - Publication Year :
- 2015
-
Abstract
- The ongoing Ebola outbreak in West Africa has resulted in fast-track development of vaccine candidates. We tested a vesicular stomatitis virus vector expressing Ebola virus glycoprotein for safety in pigs. Inoculation did not cause disease and vaccine virus shedding was minimal, which indicated that the vaccine virus does not pose a risk of dissemination in pigs.
- Subjects :
- Animals
Antibodies, Viral blood
Antibodies, Viral immunology
Genetic Vectors administration & dosage
Genetic Vectors immunology
Immunization
Immunoglobulin G blood
Immunoglobulin G immunology
Swine
Viral Vaccines administration & dosage
Viral Vaccines immunology
Virus Replication
Virus Shedding
DNA, Recombinant
Ebolavirus genetics
Genetic Vectors adverse effects
Genetic Vectors genetics
Vesicular stomatitis Indiana virus genetics
Viral Vaccines adverse effects
Viral Vaccines genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1080-6059
- Volume :
- 21
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Emerging infectious diseases
- Publication Type :
- Academic Journal
- Accession number :
- 25811738
- Full Text :
- https://doi.org/10.3201/eid2104.142012